ENSURE ALL INDIVIDUALS WITH
GENETIC RISKS FOR HEREDITARY
CANCERS RECEIVE IMPROVED
ACCESS TO EXPANDED COVERAGE
Up to 10% of all cancers are caused by cancer-related genetic mutations.
Genetic testing can play a vital role in determining the risk of developing certain diseases, as well as the need for screening or treatment. Expanded access to genetic testing can empower patients to learn their risk and take action before conditions progress.
Reducing Hereditary Cancer Act (RHCA)
Why it's important: understanding your risk
Currently, Medicare only covers genetic testing for beneficiaries already diagnosed with cancer, regardless of family cancer history or a known genetic mutation in the family. This is problematic because knowledge of an inherited mutation can be essential to help guide decisions regarding cancer screening and prevention.
What do you mean it's not covered?
How does this act help?
Genetic testing can play a vital role in determining the risk of developing certain disThe Reducing Hereditary Cancer Act (RHCA) aims to provide expanded coverage for at-risk Medicare beneficiary individuals, particularly those with genetic risks for hereditary cancers, and addresses a pressing need for increased access to genetic counseling, testing, cancer screening, and preventive care.
Passage of the RHCA will positively impact a significant a portion of the population, and contribute directly to our collective effort to combat breast cancer and save lives through increased access to care.
Let’s get this passed!
Help us champion the Reducing Hereditary Cancer Act. Contact your elected representatives and express your support for the act—urge them to prioritize this vital legislation to improve access for at-risk individuals.
